犬における免疫媒介性慢性肝炎

Tarini Ullal¹, Sarah Shropshire²

¹Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, One Garrod Drive, Davis, CA 95616, USA.

The Veterinary clinics of North America. Small animal practice

|September 5, 2025

まとめ

犬の免疫媒介性慢性肝炎は,しばしば他の原因を除外し,インターフェース肝炎を特定することによって診断されます. 早期の免疫抑制治療は,犬の肝炎の最良の予後を示します.

科学分野:

獣医内科
犬肝病学
免疫病理学

背景:

免疫媒介の慢性肝炎は,犬における慢性肝疾患の頻繁な原因である.
臨床的徴候,検査結果,画像はしばしば非特異的であり,多くの犬は早期に亜臨床的である.
診断には,他の肝臓病因を除外し,特定の組織病理学的発見を認識する必要があります.

研究の目的:

犬の免疫媒介性慢性肝炎の診断方法を見直す
現在の治療戦略とその副作用について議論する.
早期診断と介入の重要性を強調する

主な方法:

診断作業は,銅毒症,薬物/毒素暴露,感染症,腫瘍などの差異診断を除外することを含む.
ヒストポトロジック検査は極めて重要で,インターフェース肝炎は重要な特徴である.
治療には通常,サイクロスポリン,ミコフェノラート,またはコルチコステロイドのような免疫抑制薬が含まれます.

主要な成果:

変数的な臨床表現と非特異的な診断結果は,病気の早期認識を複雑にする.
肝臓バイオプシのインターフェイス肝炎は,免疫媒介の慢性肝炎の特徴です.
免疫抑制療法は治療の基石であり,副作用を慎重に考慮する必要があります.

結論:

犬における免疫媒介性慢性肝炎の早期診断と治療は,概して良好から優れた予後を導く.
病気の進行を緩和し,患者の治療結果を最適化するために,積極的な管理が不可欠です.
犬の肝炎の長期的管理をさらに改善するために,新しい治療法に関する研究が進められています.

キーワード:

アシテスビリルビン銅サイクロスポリン肝臓ヘパトパシーイディオパシー炎症

さらに関連する動画

11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.1K

07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.9K

関連する概念動画

01:17

Chronic Bowel Disorders: Introduction

536

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

536

01:24

Chronic Pancreatitis I: Introduction

147

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

147

01:29

Chronic Pancreatitis II: Collaborative Care

127

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

127

01:25

Immunodeficiency Diseases

1.2K

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

1.2K

01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

264

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

264

関連する実験動画